XNASCLOV
Market cap1.82bUSD
Jan 10, Last price
3.64USD
1D
0.00%
1Q
-10.57%
IPO
-64.76%
Name
Clover Health Investments Corp
Chart & Performance
P/E
—
P/S
0.90
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
62.92%
Rev. gr., 5y
48.56%
Revenues
2.03b
-41.50%
Net income
-213m
L-30.14%
CFO
-116m
L-43.18%
Earnings
Mar 10, 2025
Profile
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 2,033,720 -41.50% | 3,476,687 136.19% | ||||
Cost of revenue | 2,221,116 | 3,940,594 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (187,396) | (463,907) | ||||
NOPBT Margin | ||||||
Operating Taxes | (33,443) | |||||
Tax Rate | ||||||
NOPAT | (187,396) | (430,464) | ||||
Net income | (213,361) -30.14% | (305,401) -49.49% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (5,070) | (4,962) | ||||
BB yield | 1.10% | 1.12% | ||||
| Debt | ||||||
Debt current | 1,665 | 1,827 | ||||
Long-term debt | 7,661 | 9,893 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 20,164 | 16,193 | ||||
Net debt | (353,181) | (681,683) | ||||
| Cash flow | ||||||
Cash from operating activities | (115,871) | (203,926) | ||||
CAPEX | (584) | (4,467) | ||||
Cash from investing activities | 140,013 | 95,133 | ||||
Cash from financing activities | (33,861) | (4,962) | ||||
FCF | (186,082) | (432,588) | ||||
| Balance | ||||||
Cash | 242,685 | 555,293 | ||||
Long term investments | 119,822 | 138,110 | ||||
Excess cash | 260,821 | 519,569 | ||||
Stockholders' equity | (2,162,115) | (1,569,841) | ||||
Invested Capital | 2,473,336 | 1,939,632 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 482,176 | 476,244 | ||||
Price | 0.95 2.43% | 0.93 -75.01% | ||||
Market cap | 459,080 3.71% | 442,669 -71.18% | ||||
EV | 105,899 | 156,055 | ||||
EBITDA | (184,887) | (462,720) | ||||
EV/EBITDA | ||||||
Interest | 7 | 1,363 | ||||
Interest/NOPBT | ||||||